Patent · US Active

Compositions and methods for improved T cells

US12024715B2 · kind B2 · utility

0Cited by
1References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 7, 2018
Grant dateJul 2, 2024
Priority date
Expiry dateJan 16, 2040

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2510/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides compositions and methods for generating improved T cells having increased Ezh2 activity and methods of use thereof in the treatment of cancer and chronic infection.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.